Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis

References

• Akram M, Iqbal M, Daniyal M, Khan AU. (2017). Awareness and current knowledge of breast cancer. Biol Res 50:1.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Delivery Rev 65:36–12.
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Middleton R, et al. (2011). Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 22:1726–35.
   PubMed Web of Science ®Google Scholar
• Bader R, Silvers A, Zhang N. (2011). Polysialic acid-based micelles for encapsulation of hydrophobic drugs. Biomacromolecules 12:314–20.
   PubMed Web of Science ®Google Scholar
• Bae Y, Park K. (2011). Targeted drug delivery to tumors: myths, reality and possibility. J Controlled Release 153:198–205.
   PubMed Web of Science ®Google Scholar
• Del Duca D, Werbowetski T, Del Maestro RF. (2004). Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neuro-Oncol 67:295–303.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, et al. (2019). Breast cancer statistics, 2019. CA Cancer J Clin 69:438–51.
   PubMed Web of Science ®Google Scholar
• Fang C, Shi B, Pei YY, et al. (2006). In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27–36.
   PubMed Web of Science ®Google Scholar
• Guo X, Elkashef S, Loadman P, et al. (2019). Recent advances in the analysis of polysialic acid from complex biological systems. Carbohydr Polym 224:115145.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Akita H, Harashima H. (2011). A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev 63:152–60.
   PubMed Web of Science ®Google Scholar
• Ju R, Cheng L, Qiu X, et al. (2018). Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. J Drug Targeting 26:793–805.
   PubMed Web of Science ®Google Scholar
• Kaushik P, Rawat K, Aswal V, et al. (2019). Fluorescent complex coacervates of agar and in situ formed zein nanoparticles: role of electrostatic forces. Carbohydr Polym 224:115150.
   PubMed Web of Science ®Google Scholar
• Khatoon F, Ali S, Kumar V, et al. (2022). Pharmacological features, health benefits and clinical implications of honokiol. J Biomol Struct Dyn. DOI: 10.1080/07391102.2022.2120541
   PubMed Web of Science ®Google Scholar
• Kou L, Yao Q, Sivaprakasam S, et al. (2017). Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB to deliver chemotherapeutic agents for colon cancer therapy. Drug Deliv 24:1338–49.
   PubMed Web of Science ®Google Scholar
• Li Q, Ma Y, Liu XL, et al. (2020). Anti-proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF-β1/p53 signaling pathway. Oncol Rep 44:2093–107.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang Q, Wang J, et al. (2021). Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes. Carbohydr Polym 257:117572.
   PubMed Web of Science ®Google Scholar
• Luo S, Feng J, Xiao L, et al. (2020). Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis. Biomaterials 249:120055.
   PubMed Web of Science ®Google Scholar
• Magar KT, Boafo GF, Li XT, et al. (2022). Liposome-based delivery of biological drugs. Chin Chem Lett 33:587–96.
   Web of Science ®Google Scholar
• Mahauad-Fernandez W, DeMali K, Olivier A, Okeoma C. (2014). Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis. Breast Cancer Res 16:493.
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. (2019). Cancer treatment and survivorship statistics, 2019. Ca-Cancer J Clin 69:363–85.
   PubMed Web of Science ®Google Scholar
• Nel J, Elkhoury K, Velot E, et al. (2023). Functionalized liposomes for targeted breast cancer drug delivery. Bioact Mater 24:401–37.
   PubMed Web of Science ®Google Scholar
• Perche F, Torchilin V. (2012). Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Biol Ther 13:1205–13.
   PubMed Web of Science ®Google Scholar
• Qi Zhang JW, Zhang H, Liu D, et al. (2018). The anticancer efficacy of paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an in vitro and in vivo evaluation. RSC Adv 8:24084–93.
   PubMed Web of Science ®Google Scholar
• Qian Y, Zhang J, Xu R, et al. (2021). Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment. Int J Biol Macromol 183:2215–26.
   PubMed Web of Science ®Google Scholar
• Rauf A, Patel S, Imran M, et al. (2018). Honokiol: an anticancer lignan. Biomed Pharmacother 107:555–62.
   PubMed Web of Science ®Google Scholar
• Sarrica A, Kirika N, Romeo M, et al. (2018). Safety and toxicology of magnolol and honokiol. Planta Med 84:1151–64.
   PubMed Web of Science ®Google Scholar
• Sayeh M, Hassan A. (2022). Natural lignans honokiol and magnolol as potential anticarcinogenic and anticancer agents. A comprehensive mechanistic review. Nutr Cancer 74:761–78.
   PubMed Web of Science ®Google Scholar
• Shi XJ, Zhang T, Lou HX, et al. (2020). Anticancer effects of honokiol via mitochondrial dysfunction are strongly enhanced by the mitochondria-targeting carrier berberine. J Med Chem 63:11786–800.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, Jemal A. (2023). Cancer statistics, 2023. CA Cancer J Clin 73:17–48.
   PubMed Web of Science ®Google Scholar
• Singh T, Katiyar S. (2011). Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2. Int J Oncol 38:769–76.
   PubMed Web of Science ®Google Scholar
• Wang L, Wu WW, Wang LL, Wang L, et al. (2019). Highly water-soluble solid dispersions of honokiol: Preparation, solubility, and bioavailability studies and anti-tumor activity evaluation. Pharmaceutics 11:573.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Peng CH, Zhang S, et al. (2019). Polysialic-acid-based micelles promote neural regeneration in spinal cord injury therapy. Nano Lett 19:829–38.
   PubMed Web of Science ®Google Scholar
• Wu P, Sun Y, Dong W, et al. (2019). Enhanced anti-tumor efficacy of hyaluronic acid modified nanocomposites combined with sonochemotherapy against subcutaneous and metastatic breast tumors. Nanoscale 11:11470–83.
   PubMed Web of Science ®Google Scholar
• Wu W, Xu H. (2021). Construction, characterization, and bioavailability evaluation of honokiol-loaded porous starch by melting method without any solvent. Drug Deliv 28:2574–81.
   PubMed Web of Science ®Google Scholar
• Yang J, Wang L, Huang L, et al. (2021). Receptor-targeting nanomaterials alleviate binge drinking-induced neurodegeneration as artificial neurotrophins. Exploration 1:61–74.
   Google Scholar
• Yeh P, Wang W, Chang Y, et al. (2016). Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration. Cancer Lett 370:66–77.
   PubMed Web of Science ®Google Scholar
• Yu Z, Song M, Chouchane L, Ma X. (2021). Functional genomic analysis of breast cancer metastasis: implications for diagnosis and therapy. Cancers (Basel) 13:3276.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li D, Guan S, et al. (2022). Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis. Int J Biol Macromol 203:280–91.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li S, He L, Feng X. (2023). A brief review of polysialic acid-based drug delivery systems. Int J Biol Macromol 230:123151.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang J, Liu D, et al. (2020). Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis. Carbohydr Polym 240:116325.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhou S, Hu L, et al. (2016). Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation. Int J Pharm 515:449–59.
   PubMed Web of Science ®Google Scholar